IMID Medical Journal

   Many scientific and cultural efforts are now required to personalize the medicine. Now we can affirm that we are in a new era. In fact today it is possible to identify relevant pathways for the individual drug response, at the DNA, RNA and protein level. Many interested subjects, like the pharmacological industry, doctors, geneticists and administrators of public health, should take into account the practical application of the new insights in this field. All of them should follow a common interest that is to establish the drug efficacy on the patient avoiding drug wastes and adverse drug responses